⌘K
Loading ticker…
As of 2026-08-24, Summit Therapeutics Inc. Common Stock (SMMT) has a 3-month relative strength percentile of 18 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.8%, relative volume 0.90×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SMMT is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -9.7% / -23.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SMMT is held by 22 ETFs as of May 2026. Top owner: VHT at 0.04% weight, $8M notional. Top 3 carry $22M.
Held by 60 ETFs · $392M across latest filings · largest weight 1.24% (XBI).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.04% | $8M | — |
| SCHMSchwab U.S. Mid-Cap ETF | 0.05% | $7M | — |
| QQQJ | 0.63% | $7M | +0.02 pp |
| GSEW | 0.19% | $3M | new |
| VONGVanguard Russell 1000 Growth ETF | 0.01% | $3M |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| — |
| ONEQ | 0.03% | $3M | — |
| SCHXSchwab U.S. Large-Cap ETF | 0.00% | $3M | — |
| CANC | 1.21% | $2M | +0.05 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $2M | — |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.01% | $1M | — |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SMMT Jan avg: 9.25% median: 2.01% win: 50% σ: 32.48% n: 4 2022-04-12 → 2026-07-31 | SMMT Feb avg: -5.67% median: 5.40% win: 50% σ: 30.43% n: 4 2022-04-12 → 2026-07-31 | SMMT Mar avg: -1.02% median: -4.77% win: 25% σ: 10.51% n: 4 2022-04-12 → 2026-07-31 | SMMT Apr avg: -3.63% median: -5.07% win: 40% σ: 22.80% n: 5 2022-04-12 → 2026-07-31 | SMMT May avg: 17.08% median: -16.35% win: 40% σ: 61.10% n: 5 2022-04-12 → 2026-07-31 | SMMT Jun avg: 3.78% median: -10.19% win: 40% σ: 32.14% n: 5 2022-04-12 → 2026-07-31 | SMMT Jul avg: 7.28% median: 1.00% win: 60% σ: 23.28% n: 5 2022-04-12 → 2026-07-31 | SMMT Aug avg: 1.50% median: 4.34% win: 50% σ: 21.43% n: 4 2022-04-12 → 2026-07-31 (current) | SMMT Sep avg: 17.62% median: 7.30% win: 50% σ: 35.98% n: 4 2022-04-12 → 2026-07-31 | SMMT Oct avg: -7.06% median: -8.44% win: 25% σ: 7.86% n: 4 2022-04-12 → 2026-07-31 | SMMT Nov avg: -7.02% median: -3.05% win: 25% σ: 13.69% n: 4 2022-04-12 → 2026-07-31 | SMMT Dec avg: 113.56% median: 13.17% win: 50% σ: 212.31% n: 4 2022-04-12 → 2026-07-31 |